← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 1, 2009Last known activity
Aug 21, 2018
Timeline
2000s
- Jun 1, 2003
Gradalis, Inc.— Founded
Drugs by trial phase (11 distinct, 15 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Studied for
- Bone Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Colonic Neoplasms
- Colorectal Neoplasms
- Endometrial Neoplasms
- Fallopian Tube Neoplasms
- Liver Neoplasms
- Lung Neoplasms
- Melanoma
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Bone Tissue
- Neoplasms by Histologic Type
- Neoplasms, Connective and Soft Tissue
- Neoplasms, Connective Tissue
- Neuroectodermal Tumors, Primitive, Peripheral
- Ovarian Neoplasms
- Rare Diseases
- Sarcoma
- Sarcoma, Ewing
- Uterine Cervical Neoplasms
- Uterine Neoplasms
Recent trials (22)
- NCT03842865Lead sponsorN/A—
- NCT03842865Study directorN/A—
- NCT03495921Lead sponsorPhase 3Aug 21, 2018
- NCT03495921Study directorPhase 3Aug 21, 2018
- NCT03073525Lead sponsorPhase 2May 25, 2017
- NCT03073525Study directorPhase 2May 25, 2017
- NCT02736565CollaboratorPhase 1Oct 1, 2016
- NCT02725489CollaboratorPhase 2Jun 3, 2016
- NCT02639234Lead sponsorPhase 2Mar 1, 2016
- NCT02639234Study directorPhase 2Mar 1, 2016
- NCT02574533Lead sponsorPhase 1Oct 1, 2015
- NCT02574533Study directorPhase 1Oct 1, 2015
- NCT02511132Study directorPhase 2Jul 1, 2015
- NCT02511132Lead sponsorPhase 2Jul 1, 2015
- NCT02346747Lead sponsorPhase 3Feb 1, 2015
Details
- Founded
- Carrollton, TX, US Jun 1, 2003
- Last known activity
- Aug 21, 2018